Literature DB >> 2876555

Myopathy from surreptitious ipecac ingestion.

N L Rosenberg, S P Ringel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876555      PMCID: PMC1306950     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  8 in total

1.  Emetine myopathy.

Authors:  D D Duane; A G Engel
Journal:  Neurology       Date:  1970-08       Impact factor: 9.910

2.  Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa.

Authors:  M C Brotman; N Forbath; P E Garfinkel; J G Humphrey
Journal:  Can Med Assoc J       Date:  1981-09-01       Impact factor: 8.262

3.  Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders.

Authors:  E P Palmer; A T Guay
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

4.  Ipecac-induced myopathy simulating dermatomyositis.

Authors:  H S Bennett; A J Spiro; M A Pollack; P Zucker
Journal:  Neurology       Date:  1982-01       Impact factor: 9.910

5.  Emetine myopathy: two case reports with pathobiochemical analysis.

Authors:  H Sugie; R Russin; M A Verity
Journal:  Muscle Nerve       Date:  1984-01       Impact factor: 3.217

6.  Experimental (-) emetine myopathy. Ultrastructural and morphometric observations.

Authors:  L Bindoff; M J Cullen
Journal:  J Neurol Sci       Date:  1978-11       Impact factor: 3.181

7.  Emetine myopathy in the rat.

Authors:  W G Bradley; J D Fewings; J B Harris; M A Johnson
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

8.  Reversible ipecac myopathy.

Authors:  J E Mateer; B J Farrell; S S Chou; L Gutmann
Journal:  Arch Neurol       Date:  1985-02
  8 in total
  1 in total

1.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.